Retraction
The Association of HMGB1 Gene with the Prognosis of HCC
Paper Information
Record ID:
43762
Author(s):
Publication Date:
February 19, 2014
Retraction Date:
April 11, 2023
(2.6 years years ago)
Subjects:
Institutions:
- Department of Radiation Oncology, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong, China
- Department of Cancer Center, Affiliated Hospital of Guangdong Medical College, Zhanjiang, Guangdong, China
- Department of Science and Training, General Hospital of Guangzhou Military Command of People's Liberation Army, Guangzhou, Guangdong, China
Country:
🇨🇳 ChinaArticle Type:
Publisher:
PLoS
Open Access:
Yes
PubMed ID:
Retraction PubMed ID:
Retraction Details
Retraction Reasons:
Nature of Retraction:
Retraction
Retraction Notice:
10.1371/journal.pone.0284595Citations (60)
60
Total Citations2
Post-Retraction(3.3%)
56
Pre-Retraction1
Same DayPost-Retraction Citation Analysis
1
Within 30 days
2
Within 1 year
0
After 2+ years
91
Days since retraction (latest)
Paper citing The Association of HMGB1 Gene with the Prognosis o...
Unknown Authors
Unknown Journal
Published: Unknown
Circ_0001589/miR‐1248/HMGB1 axis enhances EMT‐mediated metastasis and cisplatin resistance in cervical cancer
Teng Ma, Jianxin Guo, Jian Han et al. (9 authors)
Molecular Carcinogenesis
Published: Jul 2023
10 citations
10 citations
91 days after retraction
The analysis of immunogenic cell death induced by ablation at different temperatures in hepatocellular carcinoma cells
Mengdong Wang, Yaxin Duan, Mao Yang et al. (7 authors)
Frontiers in Cell and Developmental Biology
Open Access
Published: Apr 2023
11 citations
11 citations
17 days after retraction
Retraction: The Association of HMGB1 Gene with the Prognosis of HCC
Unknown Authors
PLoS ONE
Open Access
Published: Apr 2023
Same day as retraction
Progress on the molecular mechanism of portal vein tumor thrombosis formation in hepatocellular carcinoma
Min Zhang, Qiuhui Ding, Chenbin Bian et al. (6 authors)
Experimental Cell Research
Published: Mar 2023
7 citations
7 citations
21 days before retraction
Construction and Validation of a Necroptosis-Related Signature Associated With the Immune Microenvironment in Liver Hepatocellular Carcinoma
Gongjun Wang, Baoning Ding, Libin Sun et al. (9 authors)
Frontiers in Genetics
Open Access
Published: Apr 2022
4 citations
4 citations
365 days before retraction
Cell Death in Hepatocellular Carcinoma: Pathogenesis and Therapeutic Opportunities
Ester Garcia‐Pras, Anabel Fernández‐Iglesias, Jordi Gracia‐Sancho et al. (4 authors)
Cancers
Open Access
Published: Dec 2021
49 citations
49 citations
474 days before retraction
Role of HMGB1 in Cisplatin-Persistent Lung Adenocarcinoma Cell Lines
Rodolfo Chavez-Dominguez, Mario Perez-Medina, José Sullivan López-González et al. (10 authors)
Frontiers in Oncology
Open Access
Published: Dec 2021
9 citations
9 citations
484 days before retraction
Circ-CSPP1 knockdown suppresses hepatocellular carcinoma progression through miR-493-5p releasing-mediated HMGB1 downregulation
Ganghua Yang, Qinhong Xu, Yong Wan et al. (6 authors)
Cellular Signalling
Published: Jun 2021
32 citations
32 citations
654 days before retraction
In Situ Vaccination as a Strategy to Modulate the Immune Microenvironment of Hepatocellular Carcinoma
Isabella Lurje, Wiebke Werner, Raphael Mohr et al. (6 authors)
Frontiers in Immunology
Open Access
Published: May 2021
47 citations
47 citations
704 days before retraction
The role of HMGB1 in gastrointestinal cancers
Nimet Yılmaz, Mustafa Yıldırım, Hanım Seval Savaş et al. (5 authors)
Archives of Medical Science - Civilization Diseases
Open Access
Published: Apr 2021
725 days before retraction
HMGB1: An overview of its roles in the pathogenesis of liver disease
Yuan-Ao Ni, Hui Chen, Hao Nie et al. (5 authors)
Journal of Leukocyte Biology
Published: Mar 2021
40 citations
40 citations
742 days before retraction
Soluble High Mobility Group Box 1 (HMGB1) Is a Promising Biomarker for Prediction of Therapy Response and Prognosis in Advanced Lung Cancer Patients
Nikolaus Handke, Alexander Rupp, Nicolai Trimpop et al. (5 authors)
Diagnostics
Open Access
Published: Feb 2021
16 citations
16 citations
780 days before retraction
Elevated HMGB1 expression induced by hepatitis B virus X protein promotes epithelial-mesenchymal transition and angiogenesis through STAT3/miR-34a/NF-κB in primary liver cancer.
Yuheng Zhang, Haozhen Ren, Jun Li et al. (14 authors)
American Journal of Cancer Research
Published: Feb 2021
26 citations
26 citations
799 days before retraction
A murine cellular model of necroinflammation displays RAGE‐dependent cytokine induction that connects to hepatoma cell injury
Malte Bachmann, Laura Lamprecht, Sina Gonther et al. (5 authors)
Journal of Cellular and Molecular Medicine
Open Access
Published: Jul 2020
3 citations
3 citations
993 days before retraction
Immunogenic Cell Death Driven by Radiation—Impact on the Tumor Microenvironment
Takahiro Yamazaki, Claire Vanpouille‐Box, Sandra Demaria et al. (4 authors)
Cancer treatment and research
Published: Jan 2020
15 citations
15 citations
1196 days before retraction
An indel polymorphism in the 3’ untranslated region of HMGB1 confers risk for hepatocellular carcinoma by regulating HMGB1 transcriptional activity in a Chinese population
J. Wang, Jinzhou Zhu, Da-Gan Mao et al. (6 authors)
Neoplasma
Open Access
Published: Nov 2019
2 citations
2 citations
1230 days before retraction
Quasi-ultrafine particles promote cell metastasis via HMGB1-mediated cancer cell adhesion
Rui Gao, Nan Sang
Environmental Pollution
Published: Oct 2019
22 citations
22 citations
1266 days before retraction
Bioinformatics analysis of the prognosis and biological significance of HMGB1, HMGB2, and HMGB3 in gastric cancer
Jian Fang, Xuhui Ge, Wenjing Xu et al. (9 authors)
Journal of Cellular Physiology
Published: Oct 2019
55 citations
55 citations
1273 days before retraction
<p>microRNA-548b suppresses aggressive phenotypes of hepatocellular carcinoma by directly targeting high-mobility group box 1 mRNA</p>
Zhennan Yun, Fanqi Meng, Peiqiang Jiang et al. (5 authors)
Cancer Management and Research
Open Access
Published: Jun 2019
10 citations
10 citations
1410 days before retraction
HMGB1 protein as a novel target for cancer
Alok Tripathi, Kriti Shrinet, Arvind Kumar
Toxicology Reports
Open Access
Published: Jan 2019
102 citations
102 citations
1561 days before retraction
Increased HMGB1 expression correlates with higher expression of c-IAP2 and pERK in colorectal cancer
Wenjia Zhang, Fangmei An, Min Xia et al. (6 authors)
Medicine
Open Access
Published: Jan 2019
16 citations
16 citations
1561 days before retraction
miR-505 enhances doxorubicin-induced cytotoxicity in hepatocellular carcinoma through repressing the Akt pathway by directly targeting HMGB1
Lin Lü, Donghui Zhang, Yu Xu et al. (6 authors)
Biomedicine & Pharmacotherapy
Published: May 2018
24 citations
24 citations
1782 days before retraction
Single Nucleotide Polymorphisms in HMGB1 Correlate with Lung Cancer Risk in the Northeast Chinese Han Population
Min Jiang, Xuelian Li, Xiaowei Quan et al. (5 authors)
Molecules
Open Access
Published: Apr 2018
13 citations
13 citations
1833 days before retraction
High-mobility group box 1 is a promising diagnostic and therapeutic monitoring biomarker in Cancers: A review
Seidu A. Richard
AIMS molecular science
Open Access
Published: Jan 2018
4 citations
4 citations
1926 days before retraction
MicroRNA-Mediated Regulation of HMGB1 in Human Hepatocellular Carcinoma
Jianing Yan, Shibo Ying, Xiujun Cai
BioMed Research International
Open Access
Published: Jan 2018
16 citations
16 citations
1926 days before retraction
MicroRNA-505 is downregulated in human osteosarcoma and regulates cell proliferation, migration and invasion
Yu-Jiang Liu, Wěi Li, Chang Feng et al. (6 authors)
Oncology Reports
Open Access
Published: Dec 2017
37 citations
37 citations
1947 days before retraction
High mobility group box 1 promotes sorafenib resistance in HepG2 cells and in vivo
Yinzong Xiao, Lun‐Quan Sun, Yongming Fu et al. (10 authors)
BMC Cancer
Open Access
Published: Dec 2017
15 citations
15 citations
1957 days before retraction
Increased HMGB1 expression correlates with higher expression of c-IAP2 and pERK in colorectal cancer
Wenjia Zhang
Unknown Journal
Open Access
Published: Oct 2017
1997 days before retraction
Precision diagnosis and treatment of liver cancer in China
Jing Fu, Hongyang Wang
Cancer Letters
Published: Oct 2017
283 citations
283 citations
2003 days before retraction
Paper citing The Association of HMGB1 Gene with the Prognosis o...
Unknown Authors
Unknown Journal
Published: Sep 2017
2045 days before retraction
Paper citing The Association of HMGB1 Gene with the Prognosis o...
Unknown Authors
Unknown Journal
Published: Jul 2017
2097 days before retraction
Fumigaclavine C exhibits anti-inflammatory effects by suppressing high mobility group box protein 1 relocation and release
Wanguo Yu, Zheng-Hua Pan, Yi-Xiang Zhu et al. (5 authors)
European Journal of Pharmacology
Published: Jun 2017
15 citations
15 citations
2131 days before retraction
The dual role and therapeutic potential of high-mobility group box 1 in cancer
Si-Jia He, Jin Cheng, Feng Xiao et al. (6 authors)
Oncotarget
Open Access
Published: May 2017
114 citations
114 citations
2156 days before retraction
The long non-coding RNA TP73-AS1 modulates HCC cell proliferation through miR-200a-dependent HMGB1/RAGE regulation
Shaling Li, Yan Huang, Yun Huang et al. (8 authors)
Journal of Experimental & Clinical Cancer Research
Open Access
Published: Apr 2017
139 citations
139 citations
2190 days before retraction
Paper citing The Association of HMGB1 Gene with the Prognosis o...
Unknown Authors
Unknown Journal
Published: Apr 2017
2197 days before retraction
Hepatitis B virus X protein stimulates high mobility group box 1 secretion and enhances hepatocellular carcinoma metastasis
Shuzhen Chen, Zihui Dong, Pinghua Yang et al. (15 authors)
Cancer Letters
Published: Feb 2017
58 citations
58 citations
2244 days before retraction
Paper citing The Association of HMGB1 Gene with the Prognosis o...
Unknown Authors
Unknown Journal
Published: Feb 2017
2259 days before retraction
Paper citing The Association of HMGB1 Gene with the Prognosis o...
Unknown Authors
Unknown Journal
Published: Feb 2017
2260 days before retraction
Serum and tissue markers in hepatocellular carcinoma and cholangiocarcinoma: clinical and prognostic implications
Massimiliano Berretta, Carla Cavaliere, Lara Alessandrini et al. (8 authors)
Oncotarget
Open Access
Published: Dec 2016
72 citations
72 citations
2309 days before retraction
HMGB1 induces human non-small cell lung cancer cell motility by activating integrin αvβ3/FAK through TLR4/NF-κB signaling pathway
Jianhua Zhu, Jing Luo, Yongchao Li et al. (7 authors)
Biochemical and Biophysical Research Communications
Published: Oct 2016
35 citations
35 citations
2364 days before retraction
HMGB1 overexpression as a prognostic factor for survival in cancer: a meta-analysis and systematic review
Teng‐Yun Wu, Wei Zhang, Geliang Yang et al. (7 authors)
Oncotarget
Open Access
Published: Jul 2016
130 citations
130 citations
2470 days before retraction
Paper citing The Association of HMGB1 Gene with the Prognosis o...
Unknown Authors
Unknown Journal
Published: May 2016
2518 days before retraction
Paper citing The Association of HMGB1 Gene with the Prognosis o...
Unknown Authors
Unknown Journal
Published: Mar 2016
2597 days before retraction
MicroRNA-218 modulates activities of glioma cells by targeting HMGB1.
Jianjun Gu, Rong Xu, Yaxing Li et al. (5 authors)
PubMed
Published: Jan 2016
19 citations
19 citations
2657 days before retraction
[News in severe clinical adverse drug reactions: Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN)].
Sylvia Aidé Martínez‐Cabriales, Minerva Gómez‐Flores, Jorge ge Ocampo-Candiani
PubMed
Published: Nov 2015
6 citations
6 citations
2699 days before retraction
Expression of high mobility group box 1 protein predicts a poorer prognosis for patients with osteosarcoma
Jiliang He, Peng Zhang, Qinghu Li et al. (5 authors)
Oncology Letters
Open Access
Published: Nov 2015
17 citations
17 citations
2709 days before retraction
HMGB1 promotes HCC progression partly by downregulating p21 via ERK/c-Myc pathway and upregulating MMP-2
Yanmei Chen, Chengzhao� Lin, Yang Liu et al. (4 authors)
Tumor Biology
Open Access
Published: Oct 2015
46 citations
46 citations
2726 days before retraction
The Role of HMGB1 Signaling Pathway in the Development and Progression of Hepatocellular Carcinoma: A Review
Xuanbin Wang, Longchao Xiang, Hongliang Li et al. (12 authors)
International Journal of Molecular Sciences
Open Access
Published: Sep 2015
66 citations
66 citations
2763 days before retraction
Prognostic and Predictive Value of DAMPs and DAMP-Associated Processes in Cancer
Jitka Fučíková, Irena Moserová, Linda Urbanová et al. (11 authors)
Frontiers in Immunology
Open Access
Published: Aug 2015
155 citations
155 citations
2804 days before retraction
Quick Stats
Total Citations:
60
Years Since Retraction:
2.6 years
Open Access:
Yes
Last Checked:
Jul 24, 2025